Ciamexon

This classification denotes a biological response modifier with the molecular formula C11H13N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 325PG708LF, chemically known as 2-aziridinecarbonitrile, 1-((2-methoxy-6-methyl-3-pyridinyl)methyl)- but more generally known as ciamexon, which bears US NIH Compound Identifier 71759. European Medicines Agency schedules Ciamexon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06224MIG. The term CIAMEXON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). CIAMEXON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ciamexon under HS 29333999 and SITC 51574. As of Q4 2014, CIAMEXON remains US FDA's Preferred Term for this commodity. Ciamexon bears US NLM identifiers UMLS ID C0109748 and NCI Concept Code C76067. SMILES: CC1=NC(=C(C=C1)CN2CC2C#N)OC.